Background. We report the ability to extend lung preservation up to 24 hours (24H) by using autologous whole donor blood circulating within an ex vivo lung perfusion (EVLP) system. This approach facilitates donor lung reconditioning in a model of extended normothermic EVLP. We analyzed comparative responses to cellular and acellular perfusates to identify these benefits. Methods. Twelve pairs of swine lungs were retrieved after cardiac arrest and studied for 24H on the Organ Care System (OCS) Lung EVLP platform. Three groups (n = 4 each) were differentiated by perfusate: (1) isolated red blood cells (RBCs) (current clinical standard for OCS); (2) whole blood (WB); and (3) acellular buffered dextran-albumin solution (analogous to STEEN solution). Results. Only the RBC and WB groups met clinical standards for transplantation at 8 hours; our primary analysis at 24H focused on perfusion with WB versus RBC. The WB perfusate was superior (vs RBC) for maintaining stability of all monitored parameters, including the following mean 24H measures: pulmonary artery pressure (6.8 vs 9.0 mm Hg), reservoir volume replacement (85 vs 1607 mL), and PaO 2 :FiO 2 ratio (541 vs 223). Acellular perfusion was limited to 6 hours on the OCS system due to prohibitively high vascular resistance, edema, and worsening compliance. Conclusions. The use of an autologous whole donor blood perfusate allowed 24H of preservation without functional deterioration and was superior to both RBC and buffered dextran-albumin solution for extended lung preservation in a swine model using OCS Lung. This finding represents a potentially significant advance in donor lung preservation and reconditioning.
Gothenburg, Sweden), the Vivoline System (Vivoline Medical AB, Lund, Sweden) uses STEEN and packed red blood cells (RBCs) , and the Organ Care System Lung (OCS) (TransMedics, Andover, MA) uses packed RBCs diluted in OCS Lung solution (OCS solution). 3, 4 Animal studies and some human case reports have demonstrated successful EVLP over longer intervals. Cypel and colleagues successfully preserved human and swine lungs for 12 hours on the XVIVO platform. 5 The International Randomized Study of the TransMedics Organ Care System (OCS Lung) for Lung Preservation and Transplantation (INSPIRE) trial showed the safety of OCS preservation for a mean of 4H and improved clinical outcomes compared with cold storage. 4 , 6 Ceulemans and colleagues 7 perfused human lungs up to 11H on OCS for a successful combined lung-liver transplant. The Food and Drug Administration approval International EXPAND Lung Pivotal Trial (EXPAND) trial, which makes use of OCS for extended-criteria donors, is currently enrolling human subjects with an EVLP interval limit of 12H. 8, 9 These intervals and perfusion strategies are effective for recruitment maneuvers, transportation (in the case of OCS), and assessment of most standard and extended-criteria donor lungs. However, injured lungs that require reconditioning may not be ready for transplant within this timeframe. 2 The current study evaluates 3 perfusates for 24H EVLP on OCS: RBCs without plasma, autologous whole donor blood, and acellular buffered dextran-albumin solution (BDAS). It demonstrates that the safe interval for extended preservation of swine lungs is longer than that currently in use for human lung transplantation.
MATERIALS AND METHODS

Animals
The study was approved by the local Institutional Animal Care and Use Committee. Animals received humane care in compliance with the Principles of Laboratory Animal Care and Guide for the Care and Use of Laboratory Animals. Lungs were procured from castrated male Yorkshire swine (mean weight, 82.5 ± 7.4 kg), which underwent general anesthesia with isoflurane. Baseline arterial blood gases (ABGs) were measured. The lungs were ventilated with a positive end-expiratory pressure (PEEP) of 5 mm Hg and tidal volume (TV) of 8 mL/kg.
Procurement
After sternotomy, an aortic root cannula was placed for cardioplegia administration. After ruling out gross pulmonary abnormalities, 30 000 units of heparin were administered and allowed to circulate for 3 minutes, followed by collection of 1.5 L of blood from the inferior vena cava (IVC). To achieve cardiac arrest in a manner consistent with clinical heart-lung procurement, the aorta was cross-clamped and cold cardioplegia (St. Thomas [20. 00 mM]) was delivered through the aortic root with left atrial appendage venting.
Ventilation continued at 6 mL/kg TV. Ice slush was placed around the heart and lungs. Two liters of cold (4°C) OCS solution was administered through the main pulmonary artery (PA) (50 mg nitroglycerin in first liter). 
Blood Collection
To obtain leukocyte-reduced RBCs (RBC group), blood drained from the IVC was routed to an autoLog Autotransfusion System (Medtronic PLC, Minneapolis, MN). 10 RBCs were recovered and rinsed with saline according to standard guidelines. The OCS was primed with 900 mL of isolated RBCs and 1500 mL of OCS solution, after passage through a leukocyte filter (LF). For autologous whole blood (WB) collection (WB group), 1600 mL of WB drained from the IVC, along with an additional 800 mL of OCS Lung solution, was passed through a LF and added to the OCS reservoir.
Finally, BDAS (acellular group) was produced fresh for each experiment using the published composition of STEEN solution (1000 mL contains 5 [15. 00 mM], and adjustment to a pH 7.4 with 1 M NaOH). 11, 12 The circuit was primed only with 2400 mL of BDAS.
Instrumentation and Perfusion
A cold retrograde flush of 1 L OCS solution was administered through the pulmonary vein ostia. While maintaining inflation, the trachea and main PA were cannulated. The device was primed as above before loading the lungs onto the perfusion chamber. Standard OCS Lung additives (1 g cefazolin, 200 mg ciprofloxacin, 200 mg voriconazole, 500 mg methylprednisolone, 1 vial multivitamins, 20 IU regular insulin, 4 mg milrinone, 20 mEq NaHCO 3 , 50 mg nitroglycerin, and a 50% dextrose solution) were added to the perfusate in all three groups.
Next, the lungs were installed into the OCS perfusion chamber. For the initial 30-minute assessment period, flow was slowly increased to a goal of 2.0-2.5 L/min. The lungs rewarmed to 37°C and ventilation was resumed (TV 6 mL/kg, PEEP 7 mm Hg, respiratory rate of 10 breaths/min). To allow for rewarming, the first ABG was measured 30 minutes after the start of perfusion, the arbitrary "0 hour" time point. ABG sampling was performed at 0, 2, 4, 6, 8, and 24H. Samples were analyzed using a GEM 3000 device (Instrumentation Laboratory, Bedford, MA) and the PaO 2 :FiO 2 (P:F) ratio was calculated.
Throughout the experiments, PA pressures (PAP), vascular resistance (VR), oxygen saturation, temperature, peak airway pressure (PAWP), TV, and hematocrit (HCT) were continuously monitored. Dynamic compliance (DC) was calculated using the formula DC = TV/(PAWP − PEEP). Elevations in VR over the first 30 minutes were treated with 10 mg infusions of nitroglycerin and as needed later in the experiment to maintain the mean PAP less than 20 mm Hg and to allow increases in flow for assessment.
Oxygen saturation probes were placed on both the inflow (from the oxygenator toward the PA) and outflow (from the lung basin drain toward the oxygenator) tubing. During preservation, the oxygenator and ventilator were supplied by a 12% O 2 tank and flow was maintained at 1.5 to 1.75 L/min per established guidelines. During assessment, flow was increased to 2.0 to 2.5 L/min, and the oxygenator was flushed with a 6% CO 2 /balanced N 2 gas mixture and the lungs were ventilated with 21% O 2 , supplying deoxygenated blood to the lungs and allowing assessment of graft oxygenation. Goal flows during assessment and preservation were standard for all animals.
Reservoir volumes were checked and supplemented with additional OCS solution, as needed, to maintain 500 mL or greater in the reservoir. NaHCO 3 and dextrose were administered as needed throughout to maintain bicarbonate levels greater than 20 meq/L and glucose levels greater than 70 mg/dL. Pulmonary edema was assessed using lung block weights (before and after EVLP), HCT, and reservoir volume replacement (RVR), as well as gross inspection and flexible bronchoscopy. At the completion of each experiment, the lungs were photographed, flushed with 1 L of OCS Lung solution, and tissue specimens collected.
Baseline Analyses of Inflammation
To determine the baseline level of inflammatory activation in blood perfusates, we analyzed baseline aliquots of isolated RBC, autologous whole donor blood (WB), and WB after passage through a LF (WB post-LF). We compared cell counts, inflammatory activation, and cytokine release.
Flow Cytometry
Cells were diluted 1:100 with 1X phosphate-buffered saline and collected using a Becton Dickson LSRII (BD Bioscience, San Jose, CA). Forward versus side scatter plots were generated using FlowJo software (FlowJo, Ashland, OR).
Quantitative Reverse-Transcriptase Polymerase Chain Reaction
Blood samples were homogenized in Trizol (Thermo Fisher, Grand Island, NY). RNA was extracted following manufacturer's protocol and quantitated using a nanophotometer (Implemen, Westlake Village, CA). cDNA was then generated using the Invitrogen Superscript kit (Thermo Fisher Scientific, Waltham, MA). Quantitative polymerase chain reaction using probes (Applied Biosystems, Grand Island, NY) against Swine Leukocyte Antigen DR-Alpha (SLA-DR)(Ss03389945_m1) and Cluster of Differentiation 69 (CD69)(Ss03394001_m1) was performed on an ABI7500 machine (Blue Lion Biotech, Carnation, WA).
Cytokine Analysis
Aliquots of the three different blood groups were assessed for cytokine release. IL-1b, -6, -8, and -10 were analyzed on the Luminex platform (Luminex, Austin, TX) using bead sets from Millipore (Billerica, CA).
Statistical Analyses
Preliminary analyses on variables measured every 2 minutes by the OCS Lung (DC, HCT, SaO 2 , SvO 2 , VR, and mean PAP) were done using linear mixed models to determine the frequency of measurements providing maximum power in the main analyses. Hourly measurements yield near optimal power for all outcomes and, as such, were analyzed using hourly measurements, over 24H to compare RBCs and WB and over the first 6H to compare all 3 perfusates for the main analyses. VR was also analyzed over the first 30 minutes using measurements at 2-minute increments to compare RBCs versus WB. P:F ratio was analyzed using all available measurements, at 0, 2, 4, and 6H to compare RBCs versus WB, and at 0, 2, and 4H for a 3-group comparison. Lactate and pH were analyzed using all available measurements, at 0, 2, 4, 6, 8, and 24H, to compare RBCs versus WB.
Each analysis used a mixed linear model implemented in SAS's MIXED procedure (SAS Institute Inc., Cary NC), with an exponential correlation structure (SP(EXP) in the MIXED procedure) to account for temporal dependence between measurements on a pair of lungs. Adjusted averages (accounting for missing observations, as needed) and standard errors at each time were calculated and plotted for each perfusate group. Statistical tests assessed: (1) differences between groups in group averages over all time points ("Group Effect p"); (2) differences between groups in the pattern over time ("Global Interaction p"); and (3) differences between groups at single times, indicated by marks on the horizontal axis time labels (['] for P < 0.05, ["] for P < 0.01, and (*) for P < 0.001). For the 6H/3-group comparisons, tests were done comparing group averages across time for STEEN versus RBCs and versus WB. P values are not adjusted for multiple comparisons. Lung block weight, starting osmolality, RVR, and measures of inflammatory expression were analyzed using 1-way analysis of variance (α=0.05) using GraphPad Prism 6 (GraphPad Software, La Jolla, CA). Numeric data are expressed as the mean ± standard deviation.
RESULTS
All procurements and EVLP runs were technically successful, with a mean time from procurement to initial perfusion of 20 minutes. At baseline, all lungs appeared healthy, with equal bilateral ventilation, compliance, and recoil. 
Perfusion
The acellular experiments are described separately. In all cellular experiments, goal flow rates for preservation and ABG assessment were achieved. The trend of lactate production was similar in both cellular groups, with greater overall production in the WB group (P < 0.05, Figure 1A ). pH was maintained in each cellular group with the addition of NaHCO 3 , although it was generally lower in the RBC group (P < 0.01, Figure 1B) . Administration of NaHCO 3 and dextrose was volumetrically similar in the cellular groups over 24H. More dextrose replacement was required in the WB group (9.2 ± 1.7 g vs 3.3 ± 1.9 g).
Pulmonary Physiology
VR was universally elevated at the start of EVLP but recovered by 20 minutes of perfusion ( Figure 1C ). In the WB group, VR steadily decreased over 24H (Figure 2A ). In the RBC group, VR rose sharply after 8H of perfusion (P < 0.0001). PAP gradually decreased and DC gradually increased with time in the WB group, whereas the opposite was observed in the RBC group (Figures 2B-C) . DC had a better initial trend in the RBC group but this reversed at 10H of perfusion (P < 0.05). Frothy airway edema usually developed around this time, likely a contributing factor to this finding. Metabolic and initial perfusion characteristics on OCS Lung. A, Over the initial 12 hours, lactic acid production steadily increased in both groups and overall lactate production was significantly greater in the WB group. B, pH remained essentially stable in each group with the addition of bicarbonate, but was slightly lower throughout in the RBC group. C, At the start of EVLP, VR decreased as the lungs recovered from cold ischemia and gradually rewarmed to 37°C. Ventilation was initiated at approximately 10 minutes after the start of perfusion and the initial assessment was performed at 30 minutes. There was no significant difference in initial or 30-minute VR between groups. Oxygenation P:F ratio is an important indicator of general lung function and quality and a value of 300 or greater is considered standard for acceptance in clinical transplantation. In this study, both groups had a similar P:F ratio up to 6H, indicating suitability for transplantation ( Figure 3A) . However, beyond this point, P:F ratio was undetectable in all but one of the RBC group due to edema and intolerance of assessment flow rates. In the WB group, the mean P:F ratio steadily improved over 24H ( Figure 3C ). Measured systemic arterial (SaO 2 ) and venous (SvO 2 ) oxygen saturation was maintained over 24H in the WB group, whereas each deteriorated after 12H in the RBC group (Figures 3B and D) .
Macroscopic and Histologic Assessment
Global edema primarily occurred in the RBC group. Edema was appreciable on gross inspection by 12H and it became impressive by 24H ( Figure 4A ). Gross edema was minimal at 24H in the WB group ( Figure 4D ). These findings were confirmed on flexible bronchoscopy ( Figures 4B and E) . Histologic analysis after 24H showed diffuse alveolar hemorrhage and loss of interstitial architecture in the RBC group but normal architecture in the WB group ( Figures 4C and F) .
Acellular Versus Cellular: 6H Perfusion
VR increased markedly after 3H of perfusion in the acellular group. All acellular experiments (n = 4) were aborted by 6H due to excessive VR, RVR, and profound edema ( Figures 5A, B, E) . By comparison, the VR was stable at 6H in both cellular groups with the lowest values noted in the RBC group (P < 0.01). PAP also diverged at 2-3H and was highest in the acellular group and lowest in the RBC group (P < 0.01, Figure 5B ). DC trended down in the acellular group after 3H, but remained stable in both cellular groups (P < 0.001, Figure 5C ). P:Fs in the cellular groups were consistently greater than 300 over the first 6H but fell below this level in the acellular group after only 1H to 2H ( Figure 5D ). ABGs beyond 4H were unmeasurable in the acellular group. Gross pulmonary edema was obvious after 6H of acellular perfusion ( Figure 5E ).
Pulmonary Edema During EVLP
Baseline osmolality and HCT levels were similar between both cellular groups ( Figures 6A and D) . The baseline osmolality in the acellular group was slightly lower than the others (P < 0.05, Figure 6A ). Beyond 8H, HCT increased in the RBC group, suggesting progressive edema. HCT remained stable in the WB group over 24H ( Figure 6D ).
RVR is a sensitive predictor of pulmonary edema. Figure 6B shows the net RVR over the course of the experiments (24H for cellular and 6H for acellular). During the initial 6-8H, RVR in the RBC group was minimal but increased significantly after this point and repeated boluses or continuous drips of OCS solution were required to maintain any volume in the reservoir. As such, volume requirements over 24H were significantly higher in the RBC group (P < 0.05). The reservoir volume was stable over 24H in the WB group; the only volume added was that required for dextrose and NaHCO 3 repletion. In the acellular group, RVR at 6H approximated that seen after 24H in the RBC group.
The mean weight of the lung blocks at the start of each experiment did not differ significantly between groups. The mean weight was 836 ± 147 g in the WB group and 2951 ± 43 g in FIGURE 3 . Improved oxygenation in lungs perfused with autologous WB. A, Serum P:F ratios over the first 6H of EVLP. This did not differ between groups at any time point over this interval. B, Arterial O 2 saturation (SaO 2 ) over 24H. C, Comparison of initial and final P:F ratios between groups. P:F was unmeasurable at 24H in all but one RBC experiment due to gross pulmonary edema. D, Venous O 2 saturation (SvO 2 ). Note wide variability in SaO 2 and SvO 2 in the RBC group due to worsening frothy pulmonary edema beyond 12 hours.
the RBC group after 24H of EVLP (P < 0.0001). The mean lung block weight was 1958 ± 538 g in the acellular group at 6H, significantly greater than the WB group at 24H (P < 0.05, Figure 6C ).
RBC Preparation, Leukocyte Filtration, and Inflammatory Activation
To determine whether RBC isolation and leukocyte filtration conferred any independent inflammatory insult, the relative concentrations and activation status of leukocytes, along with concentrations of relevant cytokines, were measured in samples of WB, WB passed through a LF, and RBCs isolated via cell salvage. All samples were obtained before EVLP. Flow cytometry demonstrated a consistent concentration of leukocytes in all three samples (Figures 7A-C) . Expression of CD69 and SLA-DRA (early markers of T cell activation and differentiation) mRNA was significantly lower in the RBC group compared with WB, suggesting that cell salvage did not cause inflammatory activation ( Figure 7D ). 13, 14 WB post-LF had a lower amount of CD69 expression than the RBC group. SLA-DRA levels were low in both groups.
Concentrations of relevant cytokines (IL-1b, IL-6, IL-8, and IL-10) were also measured in each sample ( Figure 7E ). Passage through a LF did not cause a significant decrease in cytokine concentration, but significant reductions were found in the RBC group (P < 0.05). Overall, these data suggest that the RBC isolation does not create a proinflammatory milieu that was responsible for the increased lung injury observed during EVLP.
DISCUSSION
The principal finding of this study was that 24H of preservation using the OCS Lung in a swine model was possible only with autologous whole donor blood and not with RBC or BDAS perfusates. RBC perfusion without plasma in this configuration resulted in excellent initial performance, which supports its continued clinical use for standard donor lungs and short (<12H) perfusion intervals. Acellular perfusion was not compatible with this system beyond 2-3H of EVLP.
OCS Lung is the subject of 2 major international trials, INSPIRE and EXPAND, both of which use a packed RBC perfusate. 4, 6, 9 Packed RBC is a logical choice; it limits viscosity, maximizes availability, and reduces interference with other transplant teams. Also, brain dead donors have an inflammatory response that might perpetuate cytokine-mediated injury during EVLP. However, the effects of brain death include volume shifts, endocrine changes, and catecholamine surges, all of which are reduced with EVLP, even in the presence of autologous whole donor blood.
What are the potential benefits of prolonged EVLP? Thus far, EVLP has been used as a screening and early recruitment tool. 1, 8 Lungs that do not demonstrate improvement within 4 to 6H are often not transplanted. [15] [16] [17] However, there are many settings in which 4 to 6H of EVLP may be insufficient, including the presence of edema, contusions, infections, and other donor-related lung injuries. Mesenchymal stem cell, gene, and pharmacologic therapies require time for maximal effect. Donation after circulatory death (DCD) lungs suffers an unpredictable ischemia-reperfusion-induced injury that might benefit from prolonged EVLP assessment before transplant. 18 Finally, clinical logistical issues can be alleviated with longer periods of time on EVLP.
Until now, the collateral insult caused by prolonged perfusion with acellular solutions or packed RBC has not been clearly demonstrated. In clinical practice, packed RBC units damaged by age or trauma harbor increased free hemoglobin, iron, and blood cell fragments. 19, 20 Iron and free heme FIGURE 6 . Decreased pulmonary edema after autologous WB perfusion. A, Plot of baseline osmolality values (n = 4 for each group). Findings show no difference between cellular groups, but the acellular group started at lower osmolality. B, RVR was significantly increased in the RBC and acellular groups compared to autologous WB, also reflecting parenchymal fluid loss. C, Final lung block weight was significantly increased in the RBC and acellular groups compared with the autologous WB groups after EVLP. Note that "final" signifies 24H for cellular groups and 6H for the acellular group. D, HCTwas similar between the WB and RBC groups over the initial 8H, but increased after this point in the RBC group, suggesting ongoing fluid loss into the lung parenchyma. HCT was necessarily unmeasurable in the acellular group.
produce oxidant-induced cellular damage. 21 In culture, Qing and colleagues showed that lung endothelial cells undergo necrotic cell death with prolonged RBC exposure. 22 In cardiac surgery, packed RBC transfusions have been linked to pulmonary dysfunction and decreased survival. 23, 24 Lungs appear to be susceptible to packed RBC-induced injury in critically ill patients. 25, 26 The reason why the RBC group did worse must also be, at least in part, due to the lack of plasma. The process of procurement and subsequent initiation of EVLP carries an ischemia-reperfusion insult that may lead to endothelial dysfunction, sequelae of which may be exacerbated by the disordered or absent fibrinolytic mechanisms inherent to an RBC-rich but plasma-poor perfusate. 27 WB maintains clotting factors and platelets that prevent propagation of injury which may be important in EVLP platforms. The components in WB plasma may help to mitigate early injury before it becomes severe, but this question requires further investigation.
An EVLP platform is an unnatural environment for prolonged lung storage. No matter how well-designed, there is potential for parenchymal irritation, microvascular damage, regional malperfusion, and alveolar trauma. Although we did not directly measure indicators of hemolysis, such as serum-free hemoglobin or lactate dehydrogenase, there was no difference in serum potassium levels (also indicative of hemolysis) between groups at any time point in our study.
Other reasons for worse performance in the RBC group, such as protein concentration and inflammatory activation by cell salvage, were addressed. The baseline osmolality and HCT levels were similar. The inflammatory marker assays showed greater baseline inflammation in WB compared with RBCs. The increased CD69 in RBCs compared with post-LF WB will require further investigation as a potential inciting factor.
How do we explain the findings with acellular perfusion? Used as the perfusate in the XVIVO and Vivoline systems, STEEN solution has a composition that mimics the lung's intravascular composition without RBCs. Vivoline does add RBC but the XVIVO system has had significant success without the use of RBC. 3, 5, 15 It is difficult to compare and contrast these systems since they have inherently different designs. In the OCS device, flow and HCT sensors are optimized for performance using a blood-based perfusate. It is not intended for acellular perfusion.
Moreover, OCS uses an open left atrium, compared with XVIVO, which uses a closed atrium with controlled atrial pressures. Low pressure from an open left atrium can result in capillary collapse and pulmonary edema when the airway pressures increase. [28] [29] [30] The OCS system maintains mean airway pressures well below the 15 to 20 mm Hg range, above which pulmonary edema is observed in rabbit models with low atrial pressures. 29 Despite this, with all conditions being equal, the acellular perfusate performed significantly worse than the blood-based perfusates for extended preservation in this setting.
Limitations
These results may not be directly applicable to human lungs but provide a foundation for further investigation. WB transfusion has been associated with favorable results in both civilian and military settings. 31 It is conceivable that our results may be different with actual banked RBC. Study lungs were not transplanted after EVLP, preventing assessment of posttransplant performance. This was a preclinical evaluation to determine markers of successful preservation on during prolonged EVLP. Subsequent studies will address the effects of prolonged preservation on a second ischemiareperfusion injury occurring after transplant. In our clinical experience, there is no value in transplanting lungs that do not meet transplant criteria on OCS and, thus, it would not have been useful to transplant the prolonged packed RBC or acellular lungs. Finally, animals were sedated but not brain dead at the time of cardiac arrest and procurement. Future studies should address the effect of brain death on the blood used for EVLP.
CONCLUSIONS
Swine lungs exposed to prolonged perfusion on the OCS Lung system with autologous whole donor blood-but not with RBCs or an acellular STEEN-like solution-were viable for transplantation at 24H. RBC is the ideal perfusion strategy for short EVLP intervals (<10-12H) in healthy donor lungs. This has been supported in human clinical trials. However, for lungs requiring a longer period of reconditioning, serious consideration should be given to the use of WB. Future studies should address how the mode of donation (brain death vs DCD) impacts the inflammatory milieu in the donor blood and whether this has an effect on prolonged EVLP.
